
Weight management in T2D
Weight and obesity are modifiable risk factors for diabetes onset and progression, with obesity management linked to a delay in progression from prediabetes to T2D, and to T2D progression.
To learn more about weight management in T2D, please sign in or register for a free account with Medthority.
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
Pharmacological weight loss strategies for T2D
Professor Caroline Apovian gives an overview of the pharmacological weight loss strategies for type 2 diabetes (T2D) in the video below.
Pharmacological weight loss strategies for T2D
Strategies for weight management include diet modification, physical and behavioural therapy, pharmacological treatments, medical devices and metabolic surgery.
To learn more about weight management in T2D, please sign in or register for a free account with Medthority.
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
Patient involvement in weight management
Professor Caroline Apovian discusses the importance of patient involvement and education in weight management in T2D in the following video.
Patient involvement in weight management
Patient involvement is crucial in weight management for T2D. Here are several ways patients can be involved41,42:
- Education: Patients should be educated on the importance of healthy eating habits, portion control and physical activity
- Goal setting: In consultation with their healthcare professional (HCP), patients can set realistic weight loss goals
- Healthy eating: Patients can improve their diet by limiting processed foods, sugar and saturated fats, as well as eating a healthy, balanced diet that is low in calories and high in nutrients, such as wholegrains, fruits and vegetables
- Physical activity: Patients should avoid sedentary behaviour and instead engage in regular physical activity, such as brisk walking, to aid in weight loss and overall health
- Maintain a healthy weight: Losing 1–2 pounds per week gradually can help with glucose control
- Collaboration: Patients should collaborate with their HCP to develop a customised weight-management plan
- Self-monitoring: Patients can track their progress and make adjustments as needed by regularly monitoring their weight and blood sugar levels
- Medications: Patients can consult with their HCP to see if medication is required to aid in weight management
- Adherence: Patients should consistently adhere to their exercise, diet plans and medication routine as part of their weight management regimen
- Support: Patients can seek support from friends, family or support groups to help with weight loss efforts
- Reflection: Patients should reflect on their progress and make changes to their plans as needed to achieve their goals
By being actively involved in their weight management, patients can greatly improve their chances of successfully managing T2D.
To learn more about weight management in T2D, please sign in or register for a free account with Medthority.
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
of interest
are looking at
saved
next event
This activity is supported by an educational grant from Eli Lilly and Company, this content has been developed by IMR International (Australia) independently of the sponsor Eli Lilly, who have had no editorial input into the content. IMR International (Australia) received unrestricted educational funding from the sponsor to help provide healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.